[go: up one dir, main page]

WO2012173717A1 - Système d'évaluation vasculaire - Google Patents

Système d'évaluation vasculaire Download PDF

Info

Publication number
WO2012173717A1
WO2012173717A1 PCT/US2012/037067 US2012037067W WO2012173717A1 WO 2012173717 A1 WO2012173717 A1 WO 2012173717A1 US 2012037067 W US2012037067 W US 2012037067W WO 2012173717 A1 WO2012173717 A1 WO 2012173717A1
Authority
WO
WIPO (PCT)
Prior art keywords
selection
user
site
information
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/037067
Other languages
English (en)
Inventor
Noelle Leslie BARNETT
Vltas Jonas SIPELIS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covidien LP
Original Assignee
Covidien LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Covidien LP filed Critical Covidien LP
Priority to EP12724212.1A priority Critical patent/EP2721537A1/fr
Publication of WO2012173717A1 publication Critical patent/WO2012173717A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture

Definitions

  • the subject technology relates to aiding treatment of a medical condition.
  • every instance of a medical condition e.g., a vascular disease
  • a medical condition e.g., a vascular disease
  • some treatment options may be better for one instance of a medical condition with a particular set of characteristics than for another instance with different characteristics. Identifying, updating, and recalling which treatment options are preferred for a particular set of characteristics of a medical condition may be difficult.
  • one or more treatment options may be identified, if they involve the use of medical devices or drugs, it may be difficult to determine which of the options is best for use in a given patient.
  • a method of aiding interventional treatment of a vascular disease comprising:
  • vascular area comprising at least one of an arterial bifurcation and a venous confluence
  • a plurality of regions of interest at locations in the representation, each of the regions representing a distinct anatomic site of an event at the vascular area
  • the event comprises at least one of thrombosis, rupture, and bleeding;
  • the item of clinical information comprises a selection of at least one therapeutic device type suitable for treating the diseased portion, wherein selection of the at least one therapeutic device type is based on at least one of the first selection and the second selection.
  • the information about a particular therapeutic device comprises at least one of device features, device benefits, case reports associated with the device, device configurations, and a summary of studies associated with the device.
  • the item of clinical information comprises at least one treatment option associated with the first selection and the second selection.
  • a machine-readable medium comprising instructions stored therein, which when executed by a machine, cause the machine to perform operations comprising:
  • each member of the second set comprising at least one of a shape and a size of the diseased portion associated with the first member
  • the item of clinical information comprises a selection of at least one therapeutic device type suitable for treating the diseased portion, wherein selection of the at least one therapeutic device type is based on at least one of the first selection and the second selection.
  • a system for aiding interventional treatment of a vascular disease comprising:
  • an output interface configured to present data
  • an input interface configured to receive input data
  • a processor configured to:
  • each member of the second set comprising at least one of a shape and a size of the diseased portion associated with the first member
  • a method of aiding treatment of a medical condition comprising:
  • displaying at an interface (i) a graphical representation of at least a portion of a body, and (ii) a plurality of regions of interest at locations in the representation, each of the regions representing a distinct anatomic site of an event at the body; receiving from a user a first selection, of a first of the regions, the first region representing a first site among the plurality of anatomic sites;
  • each member of the second set compri sing at least one of a shape and a size of the diseased portion associated with the first member
  • the item of clinical information comprises a selection of at least one therapeutic device type suitable for treating the diseased portion, wherein selection of the at least one therapeutic device type is based on at least one of the first selection and the second selection.
  • a machine-readable medium comprising instructions stored therein, which when executed by a machine, cause the machine to perform operations comprising:
  • each member of the second set comprising at least one of a shape and a size of the diseased portion associated with the first member
  • the item of clinical information comprises a selection of at least one therapeutic device type suitable for treating the diseased portion, wherein selection of the at least one therapeutic device type is based on at least one of the first selection and the second selection.
  • a system for aiding treatment of a medical condition comprising:
  • an output interface configured to present data
  • an input interface configured to receive input data
  • a processor configured to:
  • each member of the second set comprising at least one of a shape and a size of the diseased portion associated with the first member
  • FIG. 1 is a conceptual block diagram illustrating an environment 100 for aiding treatment of a medical condition, in accordance with various aspects of the subject technology.
  • FIG. 2 is a flow chart illustrating a process for aiding treatment of a vascular disease are disclosed, in accordance with various aspects of the subject technology.
  • FIG. 3 is a graphical interface that displays a graphical representation of a vascular area, in accordance with some aspects of the subject technology.
  • FIG. 4 is a graphical interface that displays a first set of morphologies, in accordance with some aspects of the subject technology.
  • FIG. 5 is a graphical interface that displays a second set of morphologies, in accordance with some aspects of the subject technology.
  • FIG. 6A is a portion of a graphical interface that displays items of clinical information, in accordance with some aspects of the subject technology.
  • FIG. 6B is a portion of a graphical interface that displays items of clinical information, in accordance with some aspects of the subject technology.
  • FIG. 6C is a graphical interface that displays items of clinical information, in accordance with some aspects of the subject technology.
  • FIG. 7A is a portion of a graphical interface that displays items of clinical information, in accordance with some aspects of the subject technology.
  • FIG. 7B is a portion of a graphical interface that displays items of clinical formation, in accordance with some aspects of the subject technology.
  • FIG. 8A is a portion of a graphical interface that displays items of clinical information, in accordance with some aspects of the subject technology.
  • FIG. 8B is a portion of a graphical interface that displays items of clinical information, in accordance with some aspects of the subject technology.
  • FIG. 8C is a graphical interface that displays items of clinical information, in accordance with some aspects of the subject technology.
  • FIG. 9 is a graphical interface that displays items of clinical information, in accordance with some aspects of the subject technology.
  • FIG. 1 OA is a portion of a graphical interface that displays items of clinical information, in accordance with some aspects of the subject technology.
  • FIG. 10B is a portion of a graphical interface that displays items of clinical iformation, in accordance with some aspects of the subject technology.
  • FIG. 11 is a block diagram illustrating a computer system with which any of the clients and servers of FIG. 1 may be implemented.
  • a phrase such as "an aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology.
  • a disclosure relating to an aspect may apply to all configurations, or one or more configurations.
  • An aspect may provide one or more examples of the disclosure.
  • a phrase such as “an aspect” may refer to one or more aspects and vice versa.
  • a phrase such as “an embodiment” does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology.
  • a disclosure relating to an embodiment may apply to all embodiments, or one or more embodiments.
  • An embodiment may provide one or more examples of the disclosure.
  • a phrase such "an embodiment” may refer to one or more embodiments and vice versa.
  • a phrase such as "a configuration” does not imply that such configuration is essential to the subject technology or that such configuration applies to all configurations of the subject technology.
  • a disclosure relating to a configuration may apply to all configurations, or one or more configurations.
  • a configuration may provide one or more examples of the disclosure.
  • a phrase such as "a configuration” may refer to one or more configurations and vice versa.
  • Such a system may guide users (e.g., doctors, nurses, other medical practitioners, patients, etc.) to various treatment options for a particular medical diagnosis or diagnosed condition in a patient by providing an interface that may be used to quickly and efficiently identify certain characteristics or morphologies associated with the patient's medical condition, determining appropriate treatment options based on the identified characteristics of the patient's medical condition, and presenting information about the treatment options to users.
  • the presented information may aid the user in making an informed decision on how to treat the patient's medical condition.
  • the presented information may also help educate users (e.g., patients or friend and family of a patient) about the potential treatment options for the patient's diagnosed medical condition.
  • FIG. 1 is a conceptual block diagram illustrating an environment 100 for aiding treatment of a medical condition, in accordance with various aspects of the subject technology.
  • FIG. 1 illustrates a single system environment 100, other aspects of the subject technology may include other configurations including, for example, client-server networked environments or peer-to-peer environments.
  • the environment 100 may include at least one user device 105 with an input interface (e.g., a touch-screen, a mouse, a keyboard, a stylus interface, a voice recognition unit, etc.), an output interface (e.g., a monitor, a speaker, etc.), and processing capabilities.
  • user device 105 may be a computer, a laptop, a mobile device (e.g., a phone, tablet, personal digital assistant (PDA)), or any other machine with a processor, memory, and input/output capabilities.
  • PDA personal digital assistant
  • the user device 105 may include an output interface 110, an input interface 120, a morphology module 130, and a treatment module 140.
  • the modules illustrated in FIG. 1 may include software instructions encoded in a medium and executed by a processor, computer hardware components, or a combination of both.
  • the modules may each include one or more processors or memories that are used to perform the functions described below.
  • the various interfaces and modules may share one or more processors or memories.
  • the interfaces and modules of FIG. 1 may work in combination to help a user identify the particular set of characteristics of a patient's known medical condition and one or more treatment options that fit those set of characteristics of the patient's medical condition.
  • the client device 105 may be used to identify a region of interest that represents a distinct anatomic site in the patient's body where an event or medical condition occurred. Based on where in the patient's body the event or medical condition occurred, the client device 105 may present a set of morphologies to the user to enable the user to further characterize the patient's medical event or condition.
  • the client device 105 may generate further sets of morphologies based on the characteristics already specified by the user in order to further identify characteristics of the patient's medical condition and eventually present the user with a number of treatment options directed to the patient's medical diagnoses and information about the treatment options.
  • the output interface 110 may be configured to present users with information via an output device (e.g., a monitor or a speaker).
  • the output interface 110 may generate display information to be displayed on a monitor.
  • the display information may include an interface containing a graphical representation of a body or a portion of a body as well as interaction items (e.g., buttons, links, etc.) that may enable interaction with a user.
  • interaction items e.g., buttons, links, etc.
  • Some of the interaction items displayed on a monitor may enable a user to navigate an application and select particular characteristics, morphologies, or information about treatment options associated with a known medical condition of a patient.
  • the input interface 120 may be configured to detect user interactions with the user device 105.
  • the input interface 120 may receive user selections of interaction items via an input device (e.g., a touch screen, a mouse, a keyboard, a microphone, etc.).
  • the selections may include, for example, areas of interest, morphologies, types of medical conditions, types of medical events, treatment options, therapeutic devices, or clinical information.
  • the morphology module 130 may be configured to determine a set of
  • the treatment module 140 may be configured to present the user with treatment options directed to the patient's medical diagnoses along with information that may be helpful in determining course of action or treatment plan. This information may include particular therapeutic devices, device features and benefits, case reports, charts and statistics comparing the treatment options, success rates, etc.
  • FIG. 2 illustrates a process for aiding treatment of a vascular disease according to various aspects
  • FIG. 3 - FIG. 8 illustrate particular graphical interfaces for aiding treatment of aneurysms according to various aspects.
  • FIG. 2 is a flow chart illustrating a process 200 for aiding treatment of a vascular disease, in accordance with various aspects of the subject technology.
  • the process 200 may be used to treat any type of vascular disease at any location in an organism with a vascular system, the operations in FIG. 2 will be discussed with references to the graphical interfaces illustrated in FIG. 3 - FIG. 8 in the interest of clarity.
  • the subject technology may be used to aid treatment of other types of diseases besides vascular diseases, such as pulmonary, renal, cardiac, musculoskeletal, neurological, dermatological, and gastrointestinal diseases, and others.
  • FIG. 3 is a graphical interface 300 that displays a graphical representation 305 of a vascular area, in accordance with some aspects of the subject technology. In particular, the graphical representation in FIG.
  • the graphical interface 300 is a graphical representation of the Circle of Willis 305 that may include anterior cerebral arteries, an anterior communicating artery, internal carotid arteries, posterior cerebral arteries, posterior cornmunicating arteries, etc.
  • the graphical interface 300 also includes a number of regions of interest 310 (numbered 1-6) at locations on the graphical representation of the Circle of Willis 305.
  • Each region of interest 310 represents a distinct anatomic site of an event at the vascular area (e.g., the Circle of Willis).
  • anatomic sites for aneurysms at the Circle of Willis may include the anterior communicating artery (AC A or ACOM), the internal carotid artery (ICA), the posterior communicating artery (PCOM), the basilar tip, the vertebrobasilar area, and the middle cerebral artery (MCA).
  • AC A or ACOM anterior communicating artery
  • ICA internal carotid artery
  • PCOM posterior communicating artery
  • MCA middle cerebral artery
  • additional information such as a description of the regions of interest 310 and information about the regions of interest (e.g., incidence rates) may also be shown on the graphical interface 300.
  • the regions of interest 310 on the display may be interactive and may allow users to select one of the regions of interest.
  • the input interface 120 may receive a user selection of the region of interest 310 identified by the number 2 and referring to the internal carotid artery (ICA) at the Circle of Willis.
  • ICA internal carotid artery
  • the morphology module 130 may determine a first set of morphologies that are clinically associated with the medical event at a diseased portion of the site (e.g., an aneurysm or an arteriovenous malformation at the ICA of the Circle of Willis).
  • the set of morphologies may define one or more characteristics or attributes (e.g., size, shape, color, texture, density, orientation, specific location, etc.) of the medical event at the diseased portion of the site.
  • the first set of morphologies may be displayed via the output interface 110 to the user at operation 220.
  • FIG. 4 is a graphical interface 400 that displays a first set of morphologies 405, in accordance with some aspects of the subject technology.
  • the morphologies may include, among other things, a specific aneurysm location at the ICA of the Circle of Willis (e.g., the sidewall) or a type (e.g., a complex morphology).
  • One of the displayed morphologies may be selected by a user and, at operation 225, the input interface 120 may receive a selection of one of the morphologies in the first set.
  • the morphology module 130 may determine a second set of morphologies based on the user selection of one of the first set of morphologies.
  • the second set of morphologies may include a size or shape of the diseased portion of the site associated with the selected morphology of the first set.
  • the second set of morphologies may also be displayed on the graphical interface at operation 235.
  • FIG. 5 is a graphical interface 500 that displays a second set of morphologies 510, in accordance with some aspects of the subject technology.
  • the user may have selected the "Sidewall" morphology 505 in the first set of
  • the second set of morphologies 510 may include a "Small Narrow Neck,” a “Small Wide-Neck,” and a “Large and Giant” morphologies that indicate characteristics of aneurysms on a sidewall of the ICA.
  • one of the second set of morphologies displayed to a user may be selected by a user and received by the interface module 120.
  • the received user selection may be used by the treatment module 140 to determine, at operation 245, one or more items of clinical information that may be helpful to the user in determining a treatment plan for the patient.
  • the items of clinical information may then be displayed to the user at operation 250 in, for example, a graphical interface (e.g., a landing page or display).
  • the items of clinical information may also be determined based on the various selections made by the user. As such, the clinical information may be directed to the specific location and characteristics of the patient's diagnosed medical condition.
  • the items of clinical information may be any piece of information that may help a user decide a treatment plan for patient's diagnosed vascular disease.
  • the item of clinical information may include treatment options, comparisons between treatment options, statistics and charts on the various treatment options, case reports, and studies.
  • the clinical information may also include information about therapeutic devices suitable to treat the patient's medical condition (e.g., device features, benefits, case reports for the device, device
  • links or other interface items may be used by a user to access further topics on a number of additional topics such as the natural history of a medical condition, surgical or endovascular treatment options for the medical condition, or information about treatment of particular categories of the medical condition (e.g., ruptured aneurysms).
  • FIG. 6A is a portion of a graphical interface 600 that displays items of clinical information, in accordance with some aspects of the subject technology.
  • the graphical interface 600 may be displayed to the user in response to various user selections. For example, graphical interface 600 may be displayed in response to the user selecting the "Small Narrow Neck" morphology displayed in the graphical interface 500 in FIG. 5.
  • Graphical interface 600 displays a number of items of clinical information related to small, narrow neck aneurysms located on a sidewall of the ICA.
  • Graphical interface 600 includes information about the small, narrow neck aneurysms located on the sidewall of the ICA such as prevalence information 605, information about the natural history of small, narrow neck aneurysms 610, information about surgical treatment options 615, and information about endovascular treatment options 620.
  • the information may include a summary of research, studies, or trials, information about new advancements in treatment options, statistics, charts, or other visual aids.
  • Links to additional information e.g., a link to more information about the natural history 625 of small, narrow neck aneurysms, a link to more information on ruptured aneurysm treatment, a link to more surgical treatment options, or a link to expanded endovascular treatment options
  • the items of clinical information may also include treatment options information that is associated with specific therapeutic devices or product lines that may be used.
  • FIG. 6B is a portion of a graphical interface 650 that displays items of clinical information, in accordance with some aspects of the subject technology.
  • the portion of the graphical interface 650 may appear right below the portion of the graphical interface 600 illustrated in FIG. 6A.
  • the bottom portion of the graphical interface 650 may include further information about coil embolization 655 that is associated with a particular device or product (e.g., the Axium detatchable coil system) and information about balloon assisted coiling 660 that is also associated with a particular device or product (e.g., Hyper balloons).
  • the graphical interface 650 may also include recommended treatment options 665 and links to a more information about recommended products associated with the treatment options (e.g., the Axium detachable coil system and the Hyper occlusion balloons).
  • the links may lead to additional graphical interfaces with more detailed information on each of the treatment options and associated therapeutic products.
  • FIG. 6C is a graphical interface 680 that displays items of clinical information, in accordance with some aspects of the subject technology. More specifically, FIG. 6C illustrates a natural history of small, narrow neck aneurysms that may be reached by the user selecting the natural history link 625 displayed in graphical interface 600 of FIG. 6A.
  • the natural histories of medical conditions may be a summary of one or more studies and include visual aids (e.g., charts, tables, images, graphs, etc.) to help a user digest the information.
  • FIG. 7A is a portion of a graphical interface 700 that displays items of clinical information, in accordance with some aspects of the subject technology.
  • the graphical interface 700 may be displayed in response to the user selecting the "Small Wide-Neck" morphology displayed in the graphical interface 500 in FIG. 5.
  • Graphical interface 700 includes mformation about the small, wide-neck aneurysms located on the sidewall of the ICA such as prevalence information, information about the natural history of small, wide-neck aneurysms, information about surgical treatment options, and information about endovascular treatment options.
  • a graphical interface may also display case reports, comparative outcomes, and studies that help a user decide a treatment plan.
  • FIG. 7B is a portion of a graphical interface 750 that displays items of clinical information, in accordance with some aspects of the subject technology.
  • the portion of the graphical interface 750 may appear right below the portion of the graphical interface 700 illustrated in FIG. 7 A.
  • the portion of the graphical interface 750 may also show links to various information comparing the recommended treatment options. For example, there may be links to comparative outcomes of the treatment options 755, links to case reports for one or more of the treatment options (e.g., 760, 765, 770, 775) that may be associated with a therapeutic product for that treatment option, and links to trial results (780).
  • FIG. 7B may show links to various information comparing the recommended treatment options. For example, there may be links to comparative outcomes of the treatment options 755, links to case reports for one or more of the treatment options (e.g., 760, 765, 770, 775) that may be associated with a therapeutic product for that treatment option, and links to trial results (780).
  • FIG. 8A is a portion of a graphical interface 800 that displays items of clinical information, in accordance with some aspects of the subject technology.
  • the graphical interface 800 may be displayed in response to the user selecting the "Large and Giant" morphology displayed in the graphical interface 500 in FIG. 5.
  • Graphical interface 800 includes information about large and giant or wide-neck aneurysms located on the side wall of the ICA such as prevalence information, information about the natural history of small, wide-neck aneurysms, information about surgical treatment options, and information about endovascular treatment options.
  • the graphical interface 800 may also include links to information about surgical results 805 so that users may be able to get a better understanding of the surgical options.
  • FIG. 8B is a portion of a graphical interface 850 that displays items of clinical information, in accordance with some aspects of the subject technology.
  • the portion of the graphical interface 850 may appear right below the portion of the graphical interface 800 illustrated in FIG. 8A.
  • Graphical interface 850 may display a side-by-side comparison of treatment options 815.
  • Each treatment option e.g., coil embolization, parent artery occlusion, liquid embolics, and flow diversion
  • Each treatment option e.g., coil embolization, parent artery occlusion, liquid embolics, and flow diversion
  • a therapeutic product or device e.g,.
  • Axium progressive coil, Axium MicroFX PGLA and Nylon micro filiments, Onyx HD-500, and Pipeline flow diversion device that may be used if the treatment option is selected to treat the patient's medical condition. Links to more detailed information (e.g., case reports) about the use of the therapeutic products or devices with the treatment options may also be provided.
  • FIG. 8C is a graphical interface 880 that displays items of clinical information, in accordance with some aspects of the subject technology. More specifically, FIG. 8C illustrates a graphical interface showing information about surgical outcomes of giant aneurysms that may be reached by the user selecting the natural history link 805 displayed in graphical interface 800 of FIG. 8 A.
  • the surgical outcome information may be a summary of one or more studies and include visual aids (e.g., charts, tables, images, graphs, etc.) to help a user digest the information. References may also be provided on the graphical interface 880 in order to allow users to find the studies for further research.
  • different sets of graphical interfaces and different sets of items of clinical information may be generated for each combination of user selections received from the user.
  • the items of clinical information may include charts, tables, videos, images, audio recordings, or other media that may be used to help a user determine a treatment plan for a patient's medical condition.
  • FIG. 9 is a graphical interface 900 that displays items of clinical information, in accordance with some aspects of the subject technology. More specifically, FIG. 9 illustrates a graphical interface 900 showing treatment options for ruptured aneurysms that may be reached by the user selecting the ruptured aneurysm treatment link displayed in graphical interfaces 600 of FIG. 6 A, 700 of FIG. 7A, and 800 of FIG. 8 A.
  • the graphical interface 900 includes information about ruptured aneurysms such as prevalence information, treatment options, comparative results, updates in treatment technology, and particular products that may be used to treat the ruptured aneurysms.
  • a user may be presented with items of clinical information at any point in the process.
  • the system may instead identify one or more items of clinical information and display the items of clinical information to the user on the graphical interface. Further aspects may be illustrated with reference to FIG. 10A and FIG. 10B.
  • FIG. 1 OA is a portion of a graphical interface 1000 that displays items of clinical information, in accordance with some aspects of the subject technology.
  • the graphical interface 1000 may be displayed to the user in response to various user selections. For example, graphical interface 1000 may be displayed in response to the user selecting the "Complex Morphology" in the graphical interface 400 in FIG. 4.
  • Graphical interface 1000 displays a number of items of clinical information related to aneurysms with complex morphologies (e.g., fusiform and blister aneurysms) that may be found on the ICA.
  • complex morphologies e.g., fusiform and blister aneurysms
  • Graphical interface 1000 may includes information such as prevalence information, information about the natural history of aneurysms with complex morphologies, information about surgical treatment options, and information about endo vascular treatment options. The information may include a summary of research, studies, or trials, information about difficulties with treatment options, statistics, charts, or other visual aids. Links to additional information may also be provided.
  • FIG. 10B is a portion of a graphical interface 1050 that displays items of clinical information, in accordance with some aspects of the subject technology. In some aspects, the portion of the graphical interface 1050 may appear right below the portion of the graphical interface 1000 illustrated in FIG. 10A.
  • the bottom portion of the graphical interface 1050 may include information about parent artery occlusion that is associated with a particular device or product (e.g., Axium MicroFX) and information about flow diversion that is also associated with a particular device or product (e.g., Pipeline embolization devices).
  • the graphical interface 1050 may also include recommended treatment options and links to a more information about recommended products associated with the treatment options. The links may lead to additional graphical interfaces with more detailed information on each of the treatment options and associated therapeutic products as well as comparative outcomes.
  • FIG. 11 is a block diagram illustrating a computer system with which any of the clients and servers of FIG. 1 may be implemented.
  • the computer system 1100 may be implemented using hardware or a combination of software and hardware, either in a dedicated server, or integrated into another entity, or distributed across multiple entities.
  • the example computer system 1100 includes a processor 1102, a main memory
  • the computer system 1100 may further include an input/output interface 1112 that may be configured to communicate with various input output devices such as video display units (e.g., liquid crystal (LCD) displays, cathode ray tubes (CRTs), or touch screens), an alphanumeric input device (e.g., a keyboard), a cursor control device (e.g., a mouse), or a signal generation device (e.g., a speaker).
  • video display units e.g., liquid crystal (LCD) displays, cathode ray tubes (CRTs), or touch screens
  • an alphanumeric input device e.g., a keyboard
  • a cursor control device e.g., a mouse
  • signal generation device e.g., a speaker
  • Processor 1102 may be a general-purpose microprocessor (e.g., a central processing unit (CPU)), a graphics processing unit (GPU), a microcontroller, a Digital Signal Processor (DSP), an Application Specific Integrated Circuit (ASIC), a Field Programmable Gate Array (FPGA), a Programmable Logic Device (PLD), a controller, a state machine, gated logic, discrete hardware components, or any other suitable entity that can perform calculations or other manipulations of information.
  • CPU central processing unit
  • GPU graphics processing unit
  • DSP Digital Signal Processor
  • ASIC Application Specific Integrated Circuit
  • FPGA Field Programmable Gate Array
  • PLD Programmable Logic Device
  • a machine-readable medium (also referred to as a computer-readable medium) may store one or more sets of instructions 1124 embodying any one or more of the
  • the instructions 1124 may also reside, completely or at least partially, within the main memory 1 104 and/or within the processor 1 102 during execution thereof by the computer system 1 100, with the main memory 1 104 and the processor 1102 also constituting machine-readable media.
  • the instructions 1124 may further be ti * ansmitted or received over a network 1126 via the network interface device 1120.
  • the machine-readable medium may be a single medium or multiple media (e.g., a centralized or distributed database, and/or associated caches and servers) that store the one or more sets of instructions.
  • the machine-readable medium may include the drive unit 1116, the static memory 1106, the main memory 1104, the processor 1 102, an external memory connected to the input/output interface 1112, or some other memory.
  • the term “machine-readable medium” shall also be taken to include any non-transitory medium that is capable of storing, encoding or carrying a set of instructions for execution by the machine and that cause the machine to perform any one or more of the methodologies of the embodiments discussed herein.
  • the term “machine -readable medium” shall accordingly be taken to include, but not be limited to, storage mediums such as solid-state memories, optical media, and magnetic media.
  • a system may be configured to help a user identify the particular set of characteristics of a patient's known medical condition and one or more treatment options that fit those set of characteristics of the patient's medical condition. For example, the system may be used to identify a region of interest that represents a distinct anatomic site in the patient's body where an event or medical condition occurred. Based on where in the patient's body the event or medical condition occurred, the system may present a set of morphologies to the user to enable the user to further characterize the patient's medical event or condition.
  • the system may generate further sets of morphologies based on the characteristics already specified by the user in order to further identify characteristics of the patient's medical event or condition and eventually present the user with a number of treatment options directed to the patient's medical diagnoses and information about the treatment options.
  • Some of the steps may be performed simultaneously.
  • module refers to logic embodied in hardware or firmware, or to a collection of software instructions, possibly having entry and exit points, written in a programming language, such as, for example C++.
  • a software module may be compiled and linked into an executable program, installed in a dynamic link library, or may be written in an interpretive language such as BASIC. It will be appreciated that software modules may be callable from other modules or from themselves, and/or may be invoked in response to detected events or interrupts.
  • Software instructions may be embedded in firmware, such as an EPROM or EEPROM.
  • hardware modules may be comprised of connected logic units, such as gates and flip-flops, and/or may be comprised of programmable units, such as programmable gate arrays or processors.
  • the modules described herein are preferably implemented as software modules, but may be represented in hardware or firmware.
  • modules may be integrated into a fewer number of modules.
  • One module may also be separated into multiple modules.
  • the described modules may be implemented as hardware, software, firmware or any combination thereof. Additionally, the described modules may reside at different locations connected through a wired or wireless network, or the Internet.
  • the processors can include, by way of example, computers, program logic, or other substrate configurations representing data and instructions, which operate as described herein.
  • the processors can include controller circuitry, processor circuitry, processors, general purpose single-chip or multi- chip microprocessors, digital signal processors, embedded microprocessors, microcontrollers and the like.
  • the program logic may advantageously be implemented as one or more components.
  • the components may advantageously be configured to execute on one or more processors.
  • the components include, but are not limited to, software or hardware components, modules such as software modules, object-oriented software components, class components and task components, processes methods, functions, attributes, procedures, subroutines, segments of program code, drivers, firmware, microcode, circuitry, data, databases, data structures, tables, arrays, and variables.

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • User Interface Of Digital Computer (AREA)

Abstract

L'invention concerne des systèmes et des procédés pour aider au traitement d'un état médical. Un tel procédé consiste à : afficher au niveau d'une interface (i) une représentation graphique d'au moins une partie d'une région anatomique, et (ii) des régions d'intérêt à des emplacements de la représentation, chacune des régions représentant un site anatomique d'un évènement médical; recevoir à partir d'un utilisateur une première sélection représentant un premier site parmi les sites anatomiques; déterminer un premier ensemble de morphologies du premier site, chaque élément du premier ensemble étant cliniquement associé à la survenue de l'évènement au niveau d'une partie malade du premier site; et déterminer, sur la base d'une seconde sélection par l'utilisateur, un second ensemble de morphologies du premier site, chaque élément du second ensemble comprenant au moins l'une d'une forme et d'une dimension de la partie malade associée au premier élément.
PCT/US2012/037067 2011-06-17 2012-05-09 Système d'évaluation vasculaire Ceased WO2012173717A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP12724212.1A EP2721537A1 (fr) 2011-06-17 2012-05-09 Système d'évaluation vasculaire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/162,774 2011-06-17
US13/162,774 US9202012B2 (en) 2011-06-17 2011-06-17 Vascular assessment system

Publications (1)

Publication Number Publication Date
WO2012173717A1 true WO2012173717A1 (fr) 2012-12-20

Family

ID=46177507

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/037067 Ceased WO2012173717A1 (fr) 2011-06-17 2012-05-09 Système d'évaluation vasculaire

Country Status (3)

Country Link
US (1) US9202012B2 (fr)
EP (1) EP2721537A1 (fr)
WO (1) WO2012173717A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5325293A (en) * 1992-02-18 1994-06-28 Dorne Howard L System and method for correlating medical procedures and medical billing codes
WO1996019774A1 (fr) * 1994-12-19 1996-06-27 University Of Medicine And Dentistry Of New Jersey Systeme interactif a interface graphique pour l'assistance au personnel medical en vue du diagnostic, du traitement et du suivi de patients operes ou souffrant d'un traumatisme
WO2003100542A2 (fr) * 2002-05-24 2003-12-04 Dynapix Intelligence Imaging Inc. Procede et appareil de documentation et de navigation integrative dans des images 3d multi-echelle
WO2011006241A1 (fr) * 2009-07-17 2011-01-20 Andre Douen Systèmes, procédés et articles pour gestion de présentation d’informations

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839822A (en) * 1987-08-13 1989-06-13 501 Synthes (U.S.A.) Computer system and method for suggesting treatments for physical trauma
US4945476A (en) 1988-02-26 1990-07-31 Elsevier Science Publishing Company, Inc. Interactive system and method for creating and editing a knowledge base for use as a computerized aid to the cognitive process of diagnosis
US6021404A (en) 1997-08-18 2000-02-01 Moukheibir; Nabil W. Universal computer assisted diagnosis
US7191110B1 (en) * 1998-02-03 2007-03-13 University Of Illinois, Board Of Trustees Patient specific circulation model
US7353238B1 (en) * 1998-06-12 2008-04-01 Outcome Sciences, Inc. Apparatus and methods for determining and processing medical outcomes
US20020004729A1 (en) * 2000-04-26 2002-01-10 Christopher Zak Electronic data gathering for emergency medical services
EP1305767B1 (fr) 2000-05-18 2014-03-19 Commwell, Inc. Technique de surveillance medicale a distance avec traitement video
AU2001278904A1 (en) * 2000-07-14 2002-01-30 Haltsymptoms.Com, Inc. Electronic navigation of information associated with parts of a living body
US8538770B2 (en) 2000-08-01 2013-09-17 Logical Images, Inc. System and method to aid diagnoses using cross-referenced knowledge and image databases
US20100223295A1 (en) * 2000-12-06 2010-09-02 Io Informatics, Inc. Applied Semantic Knowledgebases and Applications Thereof
WO2003032827A1 (fr) * 2001-08-03 2003-04-24 Robert Becker Procede de mesure fiable destine aux soins medicaux et a l'autosurveillance d'un patient
US20070094197A1 (en) * 2002-02-22 2007-04-26 Datena Stephen J Medical diagnosis including graphical user input
US7853899B1 (en) * 2002-12-30 2010-12-14 Sap Aktiengesellschaft Configuring and extending a user interface
US20050060205A1 (en) 2003-09-02 2005-03-17 Woods Randall K. Systems and methods for a graphical input display in an insurance processing system
US8127247B2 (en) * 2004-06-09 2012-02-28 Cognex Corporation Human-machine-interface and method for manipulating data in a machine vision system
US20060004605A1 (en) 2004-06-21 2006-01-05 Epic Systems Corporation System and method for a comprehensive interactive graphical representation of a health care facility for managing patient care and health care facility resources
US20060173858A1 (en) 2004-12-16 2006-08-03 Scott Cantlin Graphical medical data acquisition system
US7887475B1 (en) 2005-01-19 2011-02-15 ANATOM-e, L.L.C. Computer searchable anatomical database and visual key
US20060222596A1 (en) * 2005-04-01 2006-10-05 Trivascular, Inc. Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
US10016249B2 (en) 2005-09-08 2018-07-10 Gearbox Llc Accessing predictive data
US20080244375A1 (en) * 2007-02-09 2008-10-02 Healthline Networks, Inc. Hyperlinking Text in Document Content Using Multiple Concept-Based Indexes Created Over a Structured Taxonomy
JP4358262B2 (ja) * 2007-07-02 2009-11-04 ザイオソフト株式会社 医療画像処理装置およびプログラム
US20090070145A1 (en) * 2007-09-10 2009-03-12 Sultan Haider Method and system for coronary artery disease care
KR101364851B1 (ko) * 2007-09-21 2014-02-20 한국과학기술원 데이터베이스 구축하는 방법 및 상기 데이터베이스를이용한 질병분석 방법
US20090094053A1 (en) 2007-10-09 2009-04-09 Edward Jung Diagnosis through graphical representation of patient characteristics
US7818183B2 (en) 2007-10-22 2010-10-19 American Well Corporation Connecting consumers with service providers
US20090276246A1 (en) * 2008-05-01 2009-11-05 Siemens Medical Solutions Usa, Inc. Automated Interdisciplinary Plan of Care Generation System
US20090288000A1 (en) 2008-05-15 2009-11-19 Skintour Llc Interactive application for accessing information about a condition
US8321372B1 (en) * 2009-04-17 2012-11-27 Bridgehealth Medical, Inc. Computer-based system to optimize medical treatment based on consumer choice and comparative effectiveness of treatment data
US20100328235A1 (en) 2009-06-29 2010-12-30 Frederick Charles Taute Medical Code Lookup Interface
US8863031B2 (en) * 2009-07-17 2014-10-14 Andre Gene Douen Systems, methods and articles for managing presentation of information
WO2012024450A2 (fr) * 2010-08-17 2012-02-23 Wisercare Llc Système de support de décision de traitement de soin médical

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5325293A (en) * 1992-02-18 1994-06-28 Dorne Howard L System and method for correlating medical procedures and medical billing codes
WO1996019774A1 (fr) * 1994-12-19 1996-06-27 University Of Medicine And Dentistry Of New Jersey Systeme interactif a interface graphique pour l'assistance au personnel medical en vue du diagnostic, du traitement et du suivi de patients operes ou souffrant d'un traumatisme
WO2003100542A2 (fr) * 2002-05-24 2003-12-04 Dynapix Intelligence Imaging Inc. Procede et appareil de documentation et de navigation integrative dans des images 3d multi-echelle
WO2011006241A1 (fr) * 2009-07-17 2011-01-20 Andre Douen Systèmes, procédés et articles pour gestion de présentation d’informations

Also Published As

Publication number Publication date
EP2721537A1 (fr) 2014-04-23
US9202012B2 (en) 2015-12-01
US20120324402A1 (en) 2012-12-20

Similar Documents

Publication Publication Date Title
US12278005B2 (en) Artificial-intelligence-based facilitation of healthcare delivery
US20220330823A1 (en) Systems and devices for telemetry monitoring management
US20060206359A1 (en) Method and system for facilitating clinical decisions
CN103635908B (zh) 离开就绪性指标
Xiang et al. AView: an image-based clinical computational tool for intracranial aneurysm flow visualization and clinical management
KR20210113299A (ko) 대화형 유연한 데이터 제시를 위한 시스템 및 방법
US10242156B2 (en) Visualization of concurrently executing computer interpretable guidelines
WO2014055718A1 (fr) Systèmes et procédés de soutien clinique
Bosworth et al. Health information technology: meaningful use and next steps to improving electronic facilitation of medication adherence
US20160026762A1 (en) System and method for a patient dashboard
Dagliati et al. Big data as a driver for clinical decision support systems: a learning health systems perspective
WO2021122490A1 (fr) Système de configuration de surveillance de patient
Dinevski et al. Clinical decision support systems
RU2546080C2 (ru) Способ визуализации функционального состояния индивида и система для реализации способа
Gao et al. Tortuosity of parent artery predicts in-stent stenosis after pipeline flow-diverter stenting for internal carotid artery aneurysms
US9202012B2 (en) Vascular assessment system
WO2025059079A1 (fr) Facilitation basée sur l'intelligence artificielle d'une distribution de soins de santé
US10089442B2 (en) Executable guideline solution with multiple alternative views on recommended care steps
CA3214471A1 (fr) Plateforme de telesante intelligente
US12249424B2 (en) Decision-support tools for pediatric obesity
Yadav et al. Implications of Artificial Intelligence in Stroke Intervention and Care
Sharon John et al. Impact of artificial intelligence and digital twin technology on cardiovascular disease diagnosis and management challenges and future directions
CN111803804A (zh) 自适应放疗系统、存储介质及设备
Thakur et al. Machine Learning in Sustainable Healthcare
Biswas An intelligent mHealth-based adjunct to improve the management of patients with cardiovascular disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12724212

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2012724212

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012724212

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE